X
CAR-Ts – a new weapon in the fight against cancer
https://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/
immunology
More good news for AbbVie in rheumatoid arthritis
AbbVie has reported positive top-line results for its oral JAK1-selective inhibitor in rheumatoid arthritis (RA), bringing it closer to a potential new early treatment option for patients.
Janssen’s RA candidate among hot topics at EULAR
But attendees warned to expect “oceanic” weather.
Samsung Bioepis’ Remicade rival approved in EU
Merck, Sharp and Dohme’s (MSD) inflammatory diseases blockbuster Remicade (infliximab) faces further biosimilar competition after Samsung Bioepis’ rival, Flixabi, was approved in Europe.
